PBPIA
Pivotal bioVenture Partners Investment Advisor Portfolio holdings
AUM
$161M
1-Year Est. Return
58.57%
1 Year Est. Return
+58.57%
AUM
$161M
AUM Growth
+$37.8M
(+31%)
Holding
12
Top Sells
No sells this quarter
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Oculis Holding
OCS
$1.14B
| $44.7M | 27.68% |
2,300,774
|
|
||
2
Vaxcyte
PCVX
$5.5B
| $42.4M | 26.3% |
1,305,125
+594,391
|
|
||
3
Arcutis Biotherapeutics
ARQT
$2.5B
| $29.7M | 18.43% |
2,120,508
|
|
||
|
INZY
4
DELISTED
Inozyme Pharma
INZY
| $18M | 11.14% |
4,494,851
|
|
||
|
ZBIO
5
Zenas BioPharma
ZBIO
$1.13B
| $7.55M | 4.68% |
779,045
+42,400
|
|
||
6
Trevi Therapeutics
TRVI
$1.26B
| $6.27M | 3.89% |
+1,146,110
|
|
||
|
VIGL
7
DELISTED
Vigil Neuroscience
VIGL
| $4.46M | 2.76% |
560,595
|
|
||
8
Recursion Pharmaceuticals
RXRX
$2.56B
| $3.01M | 1.87% |
595,518
|
|
||
|
BIOA
9
BioAge Labs
BIOA
$186M
| $2.7M | 1.67% |
653,374
|
|
||
10
IO Biotech
IOBT
$43.2M
| $1.2M | 0.74% |
864,197
|
|
||
11
Rallybio
RLYB
$22.4M
| $813K | 0.5% |
2,404,644
|
|
||
12
Bolt Biotherapeutics
BOLT
$11M
| $546K | 0.34% |
94,573
|
|